Growing the love for investing
Results 51 - 60 of 719 : Previous 2 3 4 5 6 7 8 9 10 Next
Let's See if Exelixis Is Hiding Weakness
These two simple metrics can save you a lot of pain.
Where no pharma news falls through the cracks.
Top mutual funds are duking it out for the gold.
A Drug Market That's 366 Million Strong
Diabetes drugs have potential.
A combination treatment doesn't work.
5 Sustainable Dividends for Your Portfolio
Dividends are nice, but not necessarily enough.
Will Gilead Sciences Blow It Next Quarter?
Look here for a clue.
Is GlaxoSmithKline Working Hard Enough for You?
Keep your eye on margins.
Are Pfizer's Earnings Better Than They Look?
Don't just count the cash, time it.
Why Bristol-Myers Squibb's Earnings Are Outstanding
All cash flow is not created equal.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK